New research links noninvasive brain blood flow and oxygenation markers to hallmark Alzheimer's disease changes, suggesting early risk detection potential.
Key Details
- 1Study conducted at the Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC.
- 2Researchers used transcranial Doppler ultrasound and near-infrared spectroscopy to measure brain blood flow and oxygenation.
- 3Findings associated higher vascular function indicators with lower amyloid plaques and larger hippocampal volume.
- 4Amyloid PET imaging was also used to correlate vascular markers with known AD pathology.
- 5Techniques are less costly and more tolerable for large-scale or difficult-to-image populations than MRI or PET.
- 6Longitudinal studies are underway to assess if changes in these markers can predict cognitive decline.
Why It Matters
Demonstrating a link between vascular brain health (measured noninvasively) and established Alzheimer’s imaging findings could enable earlier and easier risk stratification. The use of noninvasive, accessible tools may facilitate broad screening and intervention research in populations unable to tolerate extensive imaging.
Source
EurekAlert
Related News
•EurekAlert
AI Accelerates Radiopharmaceuticals, Boosts Personalized Dosimetry in Cancer
Machine learning is driving advancements in radiopharmaceutical drug discovery and optimizing patient-specific dosimetry for precision cancer therapy.
•EurekAlert
Physicians Overly Trust Erroneous AI, Ignore Contradictory Evidence
Physicians tend to trust incorrect AI advice, even when evidence contradicts it, suggesting risks in clinical decision-making with AI tools.
•EurekAlert
Concerns Raised Over Unverified Datasets in AI Health Prediction Models
A new study finds widely used AI health prediction models are built on datasets with unverifiable origins, raising safety and validity concerns.